AMPIO PHARMACEUTICALS INC
COM · CUSIP 03209T109
0
institutional holders
-98 vs Q3 2022
—reported value*
0 new
0 added
0 reduced
96 sold out
net sold ≈ $1.8m (-29.6m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 98 |
| Q4 2022 | 0 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2022 | $62.0k | $1.0k | 0.02 |
| Q4 2022 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| VANGUARD GROUP INC | Sold out | -10.0m |
| BlackRock Inc. | Sold out | -4.6m |
| MILLENNIUM MANAGEMENT LLC | Sold out | -2.7m |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -1.6m |
| CVA Family Office, LLC | Sold out | -1.1m |
| SOUTHSTATE PRIVATE CAPITAL MANAGEMENT LLC | Sold out | -937.2k |
| Shilanski & Associates, Inc. | Sold out | -937.2k |
| STATE STREET CORP | Sold out | -616.0k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Sold out | -606.8k |
| COURIER CAPITAL LLC | Sold out | -540.1k |
Holders, Q4 2022
| Manager | Shares | Change |
|---|